ClinConnect ClinConnect Logo
Search / Trial NCT01390675

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry

Launched by DEUTSCHES HERZZENTRUM MUENCHEN · Jul 8, 2011

Trial Information

Current as of June 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called the Anesthesia for Catheter Aortic Valve Implantation Registry, is focused on understanding how anesthesia is managed during a specific heart procedure known as Transcatheter Aortic Valve Implantation (TAVI). TAVI is a newer option for patients with severe heart problems who might not be able to undergo traditional heart surgery. The researchers want to learn more about the challenges and techniques that anesthesiologists face during this procedure to improve patient safety and outcomes.

To participate in this trial, you need to be a patient scheduled for a TAVI procedure. The study is open to both men and women, and participants generally range in age from 65 to 74 years. If you decide to take part, you can expect to share your experiences during the procedure, which will help healthcare providers make TAVI safer and more effective for everyone. It's important to note that if a patient chooses not to participate, that decision will be respected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients undergoing transcatheter aortic valve implantation (TAVI)
  • Exclusion Criteria:
  • - Refusal by patient

About Deutsches Herzzentrum Muenchen

Deutsches Herzzentrum München (German Heart Center Munich) is a leading institution in cardiovascular medicine, dedicated to advancing research, treatment, and education in heart health. Affiliated with the Technical University of Munich, the center specializes in innovative clinical trials aimed at improving diagnostic and therapeutic approaches for heart diseases. With a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to patient-centered care, Deutsches Herzzentrum München is at the forefront of developing novel interventions and enhancing clinical outcomes in cardiovascular health.

Locations

Munich, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Patrick N Mayr, M.D.

Principal Investigator

Deutsches Herzzentrum München, Technische Universität München

Michael Joner, MD, Prof.

Principal Investigator

Deutsches Herzzentrum München, Technische Universität München

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials